Dr. Flannery received his Doctor of Pharmacy degree from the University of Kentucky, followed by completion of a PGY1 pharmacy practice residency at the Medical University of South Carolina and a PGY2 critical care specialty residency at the University of Kentucky. He currently practices in the Medical Intensive Care Unit at UK HealthCare, where he precepts pharmacy students and residents on rotation. Dr. Flannery co-coordinates the critical care elective and teaches in the Advanced Therapeutics courses, among other teaching activities at the College of Pharmacy. In addition to teaching, Dr. Flannery is actively involved in critical care research and scholarship, including prospective clinical trials in the critically ill. He is an active member of the American College of Clinical Pharmacy (ACCP), the American Society of Health-System Pharmacists (ASHP), and the Society of Critical Care Medicine (SCCM).

Flannery Alexander H, Coz-Yataco Angel Oswaldo. (2016). Acute Kidney Injury With Buffered Crystalloids vs Saline Among ICU Patients. JAMA, 315(14), 1519. Moore Melinda, Bailey Abby M, Flannery Alexander H, Baum Regan. (2016). Treatment of Diabetic Ketoacidosis With Intravenous U-500 Insulin in a Patient With Rabson-Mendenhall Syndrome: A Case Report. Journal of pharmacy practice, Flannery Alexander H, Adkins David Alan, Cook Aaron M. (2016). Unpeeling the evidence for the banana bag: Evidence-based recommendations for the management of alcohol-associated vitamin and electrolyte deficiencies in the ICU. Critical Care Medicine, 44(8), 1545-1552. Noel Z R, Thompson Bastin Melissa L, Montgomery-Yates Ashley Anne, Flannery Alexander H. (2016). Comparison of High-Dose Versus Standard Dose Oseltamivir in Critically Ill Patients With Influenza. Journal of intensive care medicine, Flannery Alexander H, Kruger P S. (2014). POINT: should patients receiving statins prior to ICU admission be continued on statin therapy? Yes. Chest, 146(6), 1431-3. Flannery Alexander H, Thompson Bastin Melissa L. (2014). Oseltamivir Dosing in Critically Ill Patients With Severe Influenza. The Annals of pharmacotherapy, 48(8), 1011-1018.